Reported Q: Q4 2025 Rev YoY: +101.2% EPS YoY: -121.3% Move: -1.59%
Kelfred Holdings Limited
1134.HK
HKD0.310 -1.59%
Exchange HKSE Sector Healthcare Industry Medical Instruments Supplies
Q4 2025
Published: Dec 31, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for 1134.HK

Reported

Report Date

Dec 31, 2025

Quarter Q4 2025

Revenue

257.73M

YoY: +101.2%

EPS

-0.02

YoY: -121.3%

Market Move

-1.59%

Previous quarter: Q2 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $257.73M up 101.2% year-over-year
  • EPS of $-0.02 decreased by 121.3% from previous year
  • Gross margin of 10.9%
  • Net income of -10.45M
  • "N/A" - N/A
1134.HK
Company 1134.HK

Swipe to view all report sections

Executive Summary

Kelfred Holdings Limited reported QQ4 2025 revenue of HKD 257.73 million, up modestly on a year-over-year basis from the prior year's Q4, with gross profit of HKD 28.10 million and a gross margin of 10.90%. Despite a slight top-line improvement, the company posted an operating loss of HKD 14.33 million and a net loss of HKD 10.45 million in the quarter, underscoring structural cost and operating leverage headwinds. The balance sheet remains healthy with a net cash position (net debt of HKD -39.55 million) and solid liquidity (current ratio ~1.9x), providing flexibility to invest in product development and capacity optimization. Management commentary (where disclosed) emphasized ongoing cost controls and a focus on higher-margin ODM/OBM capabilities, though formal guidance for 2026 was not issued in the QQ4 results release. The near-term investment thesis centers on margin normalization, selective commercial expansion, and capital discipline, with profitability stabilization as the key recalibration over the next 4–8 quarters.

Key Performance Indicators

Revenue
Increasing
257.73M
QoQ: 6.27% | YoY: 101.22%
Gross Profit
Increasing
28.10M
10.90% margin
QoQ: -9.97% | YoY: 109.09%
Operating Income
Decreasing
-14.33M
QoQ: -665.69% | YoY: -266.49%
Net Income
Decreasing
-10.45M
QoQ: -121.52% | YoY: -122.75%
EPS
Decreasing
-0.02
QoQ: -121.28% | YoY: -121.28%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 257.73 -0.02 +101.2% View
Q2 2025 242.52 -0.01 +89.4% View
Q1 2025 121.26 0.00 +22.9% View
Q4 2024 128.08 -0.01 +29.3% View
Q3 2024 128.08 -0.01 +29.3% View